There was a slightly significant increase in the number of patients treated with anti-platelet drugs in the VTE group.
← all excerpts
TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism.
1
—
—